Arkolith/Insider Trading/UBX/Form 4

Ghosh Anirvan

Chief Executive Officer, DirectorUnity Biotechnology, Inc. (UBX) · full profile →Form 4 · filed Nov 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$557
Net Open-Market Flow
-$557
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 4, 2024Sell(S)432$1.29$55776K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-122292) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML